Postmarketing Noninterventional Study Evaluating the Risk of Endometrial Cancer in Women Who Have Been Prescribed Imvexxy®First published 30/08/2021 Last updated 15/03/2024 EU PAS number: EUPAS41957StudyPlannedDownload as PDF
RTI Health Solutions (RTI-HS)FranceSpainSwedenUnited KingdomUnited Kingdom (Northern Ireland)United States First published: 21/04/2010Last updated 19/02/2024 InstitutionNot-for-profitENCePP partner